Product Information
QC IBUPROFEN 200 MG SOFTGEL is a generic product labeled by Chain Drug Marketing Association, priced at $0.0780 per EA under NDC 83324020648. Its NADAC has been published 57 times since Jul 23, 2025.
FDA first approved this application on Mar 24, 2009.
Strength
200 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324020648
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078682FDA Approved
3/24/2009
On Market Since
6/20/2025
Pharmacological Classes
Price Statistics
The NADAC for QC IBUPROFEN 200 MG SOFTGEL has been published 57 times since Jul 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0780 per EA |
|---|---|
| All-time high | $0.0816 (Jul 15, 2026) |
| All-time low | $0.0780 (Aug 19, 2026) |
| 52-week high | $0.0816 |
| 52-week low | $0.0780 |
| Median price | $0.0799 |
| Average price | $0.0800 |
| Largest weekly change | -4.0% (Aug 19, 2026) |
| Weeks tracked | 57 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QC IBUPROFEN 200 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for QC IBUPROFEN 200 MG SOFTGEL, manufactured by Chain Drug Marketing Association, is $0.0780 per EA (NDC 83324020648), effective Aug 19, 2026.
How has the price of QC IBUPROFEN 200 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for QC IBUPROFEN 200 MG SOFTGEL has held within roughly two percent of its current level. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for QC IBUPROFEN 200 MG SOFTGEL?
Since Jul 23, 2025, the NADAC for QC IBUPROFEN 200 MG SOFTGEL has ranged from a low of $0.0780 (Aug 19, 2026) to a high of $0.0816 (Jul 15, 2026), with a median of $0.0799 per EA.
Are there cheaper alternatives to QC IBUPROFEN 200 MG SOFTGEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QC IBUPROFEN 200 MG SOFTGEL in a comparable dosage form, but none are currently priced below it.
Who manufactures QC IBUPROFEN 200 MG SOFTGEL?
QC IBUPROFEN 200 MG SOFTGEL (NDC 83324020648) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.